Soyoung Park
General Partner at 1004 Venture Partners
San Francisco Bay Area
Overview
Work Experience
General Partner
2024 - Current
At 1004 Venture Partners, we are dedicated to driving transformative innovations that enhance healthy aging and longevity. Our mission is to invest in groundbreaking technologies and visionary entrepreneurs who are redefining the future of health. By focusing on pre-seed, seed, and series A stage companies, we empower the next generation of pioneers in the longevity sector. Our strategic investments fuel the development of solutions that promote longer, healthier lives. Join us in shaping a future where aging is not just about living longer but living better.
Investment Due Diligence Director
2023
Investment Due Diligence Manager
2020 - 2023
Analyst in Residence
2020 - 2020
HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" startups at the intersection of healthcare with digital technologies.
HealthTech Capital is a group of private investors dedicated to funding and mentoring new HealthTech start ups
Venture Partner
2023
VU Venture Partners is a multi-stage and multi-sector investment fund with offices in San Francisco and Hong Kong. VU's team is led by J. Skyler Fernandes, Andrew Zalasin, and James Zhang - top-performing investors with 45+ years of VC experience and a large number of successful investments such as Beyond Meat, Facebook, Uber, Twitter, Venmo, Oculus, Wish, Oscar, etc. We invest in Pre-seed through Series B rounds. Our initial investments range from $100K-$1M, and we will invest up to $10M in follow-on rounds. If you or anyone you know are raising capital for a startup, especially if it has enormous potential, please don't hesitate to reach out! #VC #VentureCapital #VUVenturePartners #VentureUniversity #VCTraining #Startups #Funding #Investments #PE #PrivateEquity
VU Venture Partners is a multi-sector and multi-stage venture capital fund and is a scalable venture capital fund platform.
Clinical FP&A Senior Manager, R&D Finance, Rare Disease
2022 - 2023
Post-merger integration of the sickle cell disease equity Oxbryta and two late-stage drug development assets
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
Finance Lead, Clinical Development Finance Planning and Analysis Senior Manager
2021 - 2023
GBT is driven by a deep and urgent desire to improve the care of Sickle Cell Disease (SCD) patients. Beyond developing medicines, we are working to shine a bright light on the disparities and inequalities faced by people living with Sickle Cell Disease (SCD). Global Clinical Product Development Financial Planning & Analysis
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Raised $969,500,000.00 from Cowen Investment Management.
Finance Project Consultant
2020 - 2020
Cost structure building for a new gene therapy pipeline
Corporate Controller Consultant, Associate Director of Accounting
2018 - 2018
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Raised $1,760,450,000.00 from Royalty Pharma, Deerfield, Federated Kaufmann Fund and Red Abbey Venture Partners.
Corporate Controller Consultant
2017 - 2017
Solar Spectrum provides technology-driven solar energy solutions to residential and commercial customers.
Finance Project Consultant
2017 - 2017
Jumio is an AI platform that enables users to establish their identity remotely to protect against fraud and other financial crime.
Raised $205,413,881.00 from Great Hill Partners.
Controller of Strategic Projects, Global Operations
2014 - 2016
Strategic global operation cost optimization projects for a $110M cost reduction
Controller of California, Global Operations
2012 - 2014
Post-acquisition Integration, new R&D pipeline commercialization, and SAP ERP system implementation
Teleflex is a manufacturing company that designs and develops medical devices for the healthcare sector.
Raised $400,000,000.00.